1Baron JF.A new hydroxyethyl starch:HES 130/0.4,voluven[J].Transfusion Alternatives in Transfusion Medicline,2000,2(2):13～21
2Waitzinger J,Bepperling F,Pabst G,et al.Effect of a new HES specification (6% HES130/0.4)on blood and plasma volumes after bleeding in 12 healthy male volunteers[J].Clin Drug Invest,1999,17(2):119～125
3Waitzinger J,Bepperling F,pabst G,et al.Phannacokinetics and tolerability of a new hydroxyethyl starch(HES) specification(HES130/0.4) specification(HES 130/0.4) after single dose infusion of 6 % or 10 % solution in healthy volunteers[J].Clin Drug invest,1998,16(2):151～160
4Ickx BE,Bepperling F,Melot C,et al.Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution[J].Br J Anesth,2003,91(2):196～202
5langeron O,Doelberg M,Ang ET,et al.Voluven,a lower substituted novel hydroxyethyl starch (HES130/0.4)caude fewer effects on coagulation in major orthopedic surgery than HES200/0.5[J].Anesth Analg,2001,92(4):855～862
6Gallandat Huet RC,Siemons AW,Baus D,et al.A novel hydroxyethyl starch (Voluven)for effective perioperative plasma volume substitution in cardiac surgery[J].Can J Anesth,2000,47(12):1207～1215
7Standl T,Burmeister MA,Schroeder F,et al.Hydroxyethyl starch (HES)130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES200/0.5 in volunteers undergoing acute normovolemic hemodilution[J].Anesth Analg,2003,96(4):936～943
8Ellger B,Freyhoff J,van Aken H,et al.High dose volume replacement using HES 130/0.4 during major surgery dose nor alter coagulation[J].Eur J Anaesth,2002,19(24):77
9FranZ A,Braunlich P,Gamsjager T,et al.The effects of hydroxyethyl starches of varying molecular weights on platelet function[J].Anesth Analg,2001,92(6):1402～1407
10Waitzinger J,Bepperling F,Pabst G,et al.Hydroxyethyl starch(HES) 130/0.4,a new HES specification.Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers[J].Drug R&D,2003,4(3):149～157
二级参考文献2
1J. Treib,J.-F. Baron,M. T. Grauer,R. G. Strauss. An international view of hydroxyethyl starches[J] 1999,Intensive Care Medicine(3):258～268
2Professor Dr. med. K. F. W. Messmer M.D.. The use of plasma substitutes with special attention to their side effects[J] 1987,World Journal of Surgery(1):69～74
